Search results
Results from the WOW.Com Content Network
Year of discovery Name of the drug Year when the synthesis mechanism was developed Year that was Patented Governmental approval Patented expired 1901: Adrenaline: Jōkichi Takamine, 1901: 1901: 1901: N/A (Natural Hormone) 1906: Oxytocin: Discovered by Henry Hallett Dale, synthesized by Vincent du Vigneaud in 1952: 1925: 1926: N/A (Natural ...
The history of medicine in the Philippines discusses the folk medicinal practices and the medical applications used in Philippine society from the prehistoric times before the Spaniards were able to set a firm foothold on the islands of the Philippines for over 300 years, to the transition from Spanish rule to fifty-year American colonial embrace of the Philippines, and up to the establishment ...
Abelardo Aguilar (November 3, 1917 – September 22, 1993 was a Filipino doctor from Iloilo, Philippines who worked as a medical representative for Eli Lilly and Company. [ 1 ] [ 2 ] Discovery of Erythromycin
In the 1940s, a method to formulate erythromycin was discovered by Dr. Abelardo Aguilar. A doctor from Iloilo, Aguilar worked for the pharmaceutical company Eli Lilly and Company as a researcher. [58] Then in 1949, he submitted samples of his work to the company's research team who in 1952 declared the discovery of a new kind of antibiotic.
Appeals judges at the International Criminal Court ruled Tuesday that an investigation into the Philippines' deadly “war on drugs” can resume, rejecting Manila’s objections to the case going ...
Despite the rise of combinatorial chemistry as an integral part of lead discovery process, natural products still play a major role as starting material for drug discovery. [55] A 2007 report [ 56 ] found that of the 974 small molecule new chemical entities developed between 1981 and 2006, 63% were natural derived or semisynthetic derivatives ...
Illegal drug trade in the Philippines; N. New Bilibid Prison drug trafficking scandal This page was last edited on 25 December 2022, at 11:53 (UTC). ...
In fiscal year 2014, SAMHSA, which helps to fund drug treatment throughout the country, had a budget of roughly $3.4 billion dedicated to a broad range of behavioral health treatment services, programs and grants.